Right to Access Life-Saving Therapies

Introduction

The right to access life-saving therapies refers to the legal and constitutional principle that individuals should have reasonable access to medical treatments necessary to protect life, prevent serious illness, or avoid premature death.

This right is particularly significant in biotechnology and pharmaceutical law because advanced therapies, including gene therapy, cancer immunotherapy, stem-cell treatments, vaccines, and treatments for rare diseases, can substantially improve survival and quality of life.

However, the availability of such treatments may be restricted by high prices, patent monopolies, inadequate healthcare infrastructure, regulatory delays, and unequal distribution of medical resources.

The central legal question is whether the government has a constitutional obligation to ensure access to life-saving therapies and whether pharmaceutical companies can be required to make essential treatments affordable.

In India, this issue is examined through Article 21 of the Constitution, the Drugs and Cosmetics Act, 1940, the Patents Act, 1970, and judicial decisions concerning healthcare, emergency medical treatment, and access to essential medicines.

2. Important Case Laws

A. Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996) 4 SCC 37

The Supreme Court held that the State has a constitutional obligation under Article 21 to provide timely medical assistance to preserve human life.

Legal principle: Access to essential treatment is an important component of the right to life.

Indian Kanoon

B. Consumer Education and Research Centre v. Union of India (1995) 3 SCC 42

The Supreme Court recognized that the right to health and medical care forms an integral part of the right to life under Article 21.

Legal principle: Human dignity requires reasonable protection of health and access to necessary medical care.

C. Novartis AG v. Union of India (2013) 6 SCC 1

The Supreme Court rejected a patent application for a modified form of the cancer drug imatinib mesylate because it did not demonstrate the required enhancement of therapeutic efficacy.

The Court emphasized balancing pharmaceutical innovation with public access to affordable medicines.

Indian Kanoon+1

Legal principle: Patent protection must not unnecessarily place life-saving medicines beyond the reach of patients.

D. Bayer Corporation v. Union of India (2014)

The Bombay High Court upheld the compulsory licence granted for Bayer's cancer drug Nexavar.

The decision emphasized affordability, public requirements, and access to essential medicines.

Global Health & Human Rights Database

Legal principle: Intellectual property rights may be limited under statutory provisions to protect public health.

3. Legal Framework in India

Article 21: Protects life and personal liberty and supports the constitutional importance of healthcare.

Article 14: Protects against arbitrary discrimination in access to medical treatment.

Patents Act, 1970: Provides compulsory licensing mechanisms that can improve access to essential medicines.

National Policy for Rare Diseases, 2021: Provides a policy framework for addressing the treatment needs of individuals with rare diseases.

4. Major Legal Issues

Affordability: High treatment costs may prevent patients from accessing life-saving therapies.

Availability: Essential medicines and advanced therapies may be unavailable in certain regions.

Patent protection: The law must balance innovation incentives with public-health requirements.

Equality: Access to life-saving treatment should not depend exclusively on economic status.

Government responsibility: The State must develop reasonable policies and healthcare infrastructure to protect life.

Conclusion

The right to access life-saving therapies is closely connected with Article 21 of the Indian Constitution. Judicial decisions such as Paschim Banga Khet Mazdoor Samity, Consumer Education and Research Centre, Novartis, and Bayer establish important principles concerning healthcare, affordability, and public welfare.

However, Indian law does not establish an absolute right to receive every available treatment regardless of cost or medical effectiveness. The legal obligation is to protect life through reasonable healthcare measures, fair access, and appropriate regulation.

The ultimate objective is to ensure that scientific progress benefits society while preserving human dignity, equality, and the right to life.